Novo Nordisk A/S (NVO) News Today $88.06 +4.33 (+5.16%) Closing price 03:59 PM EasternExtended Trading$88.10 +0.04 (+0.05%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Novo Nordisk A/S (NYSE:NVO) Stock Price Up 1.2% - Here's WhyNovo Nordisk A/S (NYSE:NVO) Trading 1.2% Higher - Here's What HappenedFebruary 21 at 8:16 PM | marketbeat.comNVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitFebruary 21 at 4:00 PM | globenewswire.comNovo Nordisk A/S (NYSE:NVO) Trading Up 5% - Should You Buy?Novo Nordisk A/S (NYSE:NVO) Shares Up 5% - Here's WhyFebruary 21 at 2:55 PM | marketbeat.comTop Growth Stocks To Add to Your Watchlist - February 21stNovo Nordisk A/S, BlackRock, and Apollo Global Management are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares in companies that are expected to grow at an above-average rate compared to other companies in the market. The main attractioFebruary 21 at 2:07 PM | marketbeat.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in Novo Nordisk A/S Lawsuit – NVOFebruary 21 at 1:48 PM | globenewswire.com“Novo Nordisk Is Up, But the Market Is Not Rational!” – Jim Cramer on Novo Nordisk A/S (NVO)February 21 at 1:35 PM | insidermonkey.comWhy Novo Nordisk Stock Popped on FridayFebruary 21 at 11:28 AM | fool.comLowey Dannenberg Notifies Novo Nordisk A/S (“Novo” or the “Company”) (NYSE: NVO) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the FirmFebruary 21 at 11:15 AM | globenewswire.comShortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA saysFebruary 21 at 11:12 AM | cnbc.comInvestors in Novo Nordisk A/S Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights - NVOFebruary 21 at 5:45 AM | prnewswire.comForte Capital LLC ADV Trims Position in Novo Nordisk A/S (NYSE:NVO)Forte Capital LLC ADV lessened its holdings in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 35.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 42,278 shares of the company's stock after sellingFebruary 21 at 5:19 AM | marketbeat.comNovo Nordisk A/S (NVO): Is It The Most Oversold Healthcare Stock to Buy Now?February 21 at 4:37 AM | insidermonkey.comBryn Mawr Capital Management LLC Purchases 30,420 Shares of Novo Nordisk A/S (NYSE:NVO)Bryn Mawr Capital Management LLC grew its holdings in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 358.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 38,898 shares of the compaFebruary 21 at 4:36 AM | marketbeat.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action – NVOFebruary 20 at 8:30 PM | globenewswire.comNovo Nordisk (NVO) Faces Securities Class Action After Weight Loss Therapy Trial Data Disappoints, Analyst Questions Trial's Design – Hagens BermanFebruary 20 at 3:22 PM | globenewswire.comNovo Nordisk A/S (NYSE:NVO) Trading Down 0.1% - Here's What HappenedNovo Nordisk A/S (NYSE:NVO) Shares Down 0.1% - Here's What HappenedFebruary 20 at 1:42 PM | marketbeat.comInvestors in Novo Nordisk A/S Should Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights – NVOFebruary 20 at 1:31 PM | globenewswire.comIs Novo Nordisk A/S (NVO) the Best Global Stock to Buy According to Hedge Funds?February 20 at 1:03 PM | msn.comNovo Nordisk A/S (NYSE:NVO) is Hussman Strategic Advisors Inc.'s 4th Largest PositionHussman Strategic Advisors Inc. raised its position in Novo Nordisk A/S (NYSE:NVO - Free Report) by 25.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 63,000 shares of the company's stockFebruary 20 at 6:37 AM | marketbeat.comNovo Nordisk A/S Sued for Securities Law Violations - Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights - NVOFebruary 20 at 5:45 AM | prnewswire.comCumberland Partners Ltd Buys New Position in Novo Nordisk A/S (NYSE:NVO)Cumberland Partners Ltd bought a new position in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 29,679 shares of the company's stock, valued atFebruary 20 at 5:42 AM | marketbeat.comPrivate Wealth Partners LLC Boosts Holdings in Novo Nordisk A/S (NYSE:NVO)Private Wealth Partners LLC increased its position in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 48.5% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 49,300 shares of the company's stock after buying an additional 16,097 shareFebruary 20 at 5:24 AM | marketbeat.comCIBC Asset Management Inc Boosts Stock Holdings in Novo Nordisk A/S (NYSE:NVO)CIBC Asset Management Inc increased its position in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 5.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 73,547 shares of the company's stock after buying an additional 3,9February 20 at 4:02 AM | marketbeat.comWhy Novo Nordisk Is A Strong Buy Despite Market ConcernsFebruary 20 at 1:01 AM | seekingalpha.com2NVO : Spotlight on Novo Nordisk: Analyzing the Surge in Options ActivityFebruary 19 at 11:26 PM | benzinga.comNovo Nordisk A/S (NYSE:NVO) Shares Down 1.1% - Here's What HappenedNovo Nordisk A/S (NYSE:NVO) Trading Down 1.1% - Here's What HappenedFebruary 19 at 6:42 PM | marketbeat.comTop Growth Stocks To Follow Now - February 19thNovo Nordisk A/S, BlackRock, Apollo Global Management, Blackstone, and Prologis are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of a company that are expected to grow at an above-average rate compared to other companies in the markeFebruary 19 at 2:11 PM | marketbeat.comSHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo NordiskFebruary 19 at 11:08 AM | globenewswire.comNovo Nordisk Sues Singapore-Based KBP Biosciences Over Alleged Data Misrepresentation In $1.3 Billion Hypertension Drug Deal, Seeks DamagesFebruary 19 at 9:32 AM | benzinga.comNovo Nordisk A/S (NYSE:NVO) Shares Purchased by DSM Capital Partners LLCDSM Capital Partners LLC raised its holdings in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 16.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,007,412 shares of the company's stock aFebruary 19 at 6:28 AM | marketbeat.comNovo Nordisk A/S (NYSE:NVO) Trading 5.3% Higher - Should You Buy?Novo Nordisk A/S (NYSE:NVO) Trading Up 5.3% - Time to Buy?February 18 at 11:38 PM | marketbeat.comNovo Nordisk A/S (NYSE:NVO) Shares Gap Up - Here's WhyNovo Nordisk A/S (NYSE:NVO) Shares Gap Up - Here's WhyFebruary 18 at 9:53 PM | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Lawsuit Against Novo Nordisk A/S - NVOFebruary 18 at 6:21 PM | prnewswire.comLevi & Korsinsky Reminds Novo Nordisk A/S Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 – NVFebruary 18 at 2:25 PM | globenewswire.comLowey Dannenberg Notifies Novo Nordisk A/S (“Novo” or the “Company”) (NYSE: NVO) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the FirmFebruary 18 at 1:08 PM | globenewswire.comNovo Nordisk alleges fraud after $1.3 billion deal to buy hypertension drug from KBP BiosciencesFebruary 18 at 9:26 AM | reuters.comBfsg LLC Raises Stock Holdings in Novo Nordisk A/S (NYSE:NVO)Bfsg LLC grew its holdings in Novo Nordisk A/S (NYSE:NVO - Free Report) by 18.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 102,992 shares of the company's stock after buying an additional 16,37February 18 at 6:39 AM | marketbeat.comNovo Nordisk A/S (NYSE:NVO) Shares Acquired by Buckingham Capital Management Inc.Buckingham Capital Management Inc. increased its position in Novo Nordisk A/S (NYSE:NVO - Free Report) by 97.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 64,078 shares of the company's stock after buFebruary 18 at 6:31 AM | marketbeat.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in Novo Lawsuit - NVOFebruary 18 at 5:45 AM | prnewswire.comNovo Nordisk A/S (NYSE:NVO) Shares Sold by Venturi Wealth Management LLCVenturi Wealth Management LLC reduced its position in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 17.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 30,629 shares of the company's stock after selling 6,603 sFebruary 18 at 5:44 AM | marketbeat.comTruist Financial Corp Sells 12,561 Shares of Novo Nordisk A/S (NYSE:NVO)Truist Financial Corp lessened its holdings in Novo Nordisk A/S (NYSE:NVO - Free Report) by 2.2% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 563,234 shares of the company's stock after selling 12,561 shares during the period. Truist Financial CoFebruary 18 at 5:25 AM | marketbeat.comCsenge Advisory Group Decreases Stake in Novo Nordisk A/S (NYSE:NVO)Csenge Advisory Group decreased its position in Novo Nordisk A/S (NYSE:NVO - Free Report) by 62.8% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 10,458 shares of the company's stock after selling 17,649 shares during the period. Csenge Advisory Group'sFebruary 18 at 4:30 AM | marketbeat.comPrincipal Securities Inc. Lowers Position in Novo Nordisk A/S (NYSE:NVO)Principal Securities Inc. lessened its stake in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 18.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 34,020 shares of the company's stock after sellingFebruary 18 at 4:14 AM | marketbeat.comNations Financial Group Inc. IA ADV Sells 10,988 Shares of Novo Nordisk A/S (NYSE:NVO)Nations Financial Group Inc. IA ADV reduced its holdings in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 63.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,250 shares of the company's stFebruary 18 at 4:02 AM | marketbeat.comROSEN, LEADING INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before ...February 17, 2025 | gurufocus.comNVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud LawsuitFebruary 17, 2025 | gurufocus.comROSEN, LEADING INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action – NVOFebruary 17, 2025 | globenewswire.comNVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud LawsuitFebruary 17, 2025 | prnewswire.comNovo Nordisk (NVO) Faces Securities Class Action After Weight Loss Therapy Trial Data Disappoints, Analyst Questions Trial's Design – Hagens BermanFebruary 17, 2025 | globenewswire.comNovo Nordisk A/S (NYSE:NVO) Stock Price Down 1.1% - What's Next?Novo Nordisk A/S (NYSE:NVO) Trading Down 1.1% - Time to Sell?February 17, 2025 | marketbeat.com Get Novo Nordisk A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for NVO and its competitors with MarketBeat's FREE daily newsletter. Email Address NVO Media Mentions By Week NVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVO News Sentiment▼0.540.60▲Average Medical News Sentiment NVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVO Articles This Week▼7934▲NVO Articles Average Week Get Novo Nordisk A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for NVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AstraZeneca News Today Novartis News Today Sanofi News Today GSK News Today Takeda Pharmaceutical News Today argenx News Today BioNTech News Today Teva Pharmaceutical Industries News Today Summit Therapeutics News Today Genmab A/S News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NVO) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Nordisk A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Novo Nordisk A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
